Ryan S. Robetorye

Dr. Ryan S. Robetorye is a faculty member in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Phoenix, Arizona, with a career spanning clinical pathology, hematopathology, and molecular diagnostics. He serves as Medical Director of the Coagulation Laboratory and Co-Medical Director of Molecular Diagnostics-Arizona Laboratory, while leading committees in point-of-care testing, genomic medicine, and laboratory accreditation.

• Education: Ph.D. in Cell Biology (1995) and MD (1997) from Baylor College of Medicine; Residency and Fellowship at University of Utah Health Sciences Center.

Research Interests: His work focuses on

• genomic profiling of lymphomas
• molecular mechanisms in hematologic malignancies
• coagulation disorders
• point-of-care testing implementation
• clinical applications of genomic technologies
• quality improvement in laboratory medicine

Publication Trends: Recent studies emphasize mantle cell lymphoma biomarkers (2024), follicular-to-DLBCL transformation (2023), and allogeneic stem cell transplantation for dendritic neoplasms (2023). Earlier work established array CGH methodology for chronic lymphocytic leukemia (2008) and thrombotic disorder updates (2001).

Scientific Recognition:

• Global Investigator Award (2020)
• Stowell-Orbison Merit Award (2003)
• NIH Hematology Training Grant (2001)
• Best Graduate Student Presentation (Baylor College of Medicine, 1997)

Leadership & Grants: As a Team Leader for CAP Inspection Teams and Chair of Point of Care Testing Committees, he has secured NIH and CAP funding for genomic medicine initiatives. His mentorship roles include supervising hematology training grants and residency programs.